Short CommunicationPreliminary evidence for a link between schizophrenia and NMDA–glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1)
Section snippets
Acknowledgments
This study was supported by grants from the Clive and Vera Ramaciotti and Rebecca Cooper Foundations. Post-mortem tissues were received from the Australian Brain Donor Programs NWS Tissue Resource Centre, which is supported by the National Health and Medical Research Council of Australia.
References (37)
- et al.
Human serine racemase: molecular cloning, genomic organization and functional analysis
Gene
(2000) - et al.
The origin and turnover of d-serine in brain
Biochem. Biophys. Res. Commun.
(1997) - et al.
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
Neurosci. Lett.
(2001) - et al.
Free d-aspartate and d-serine in the mammalian brain and periphery
Prog. Neurobiol.
(1997) - et al.
Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
Prog. Neuro-psychopharmacol. Biol. Psychiatry
(2005) - et al.
Sequential regional cerebral blood flow brain scans using PET with H215O demonstrate ketamine actions in CNS dynamically
Neuropsychopharmacology
(2001) - et al.
d-amino-acid oxidase is confined to the lower brain stem and cerebellum in rat brain: regional differentiation of astrocytes
Brain Res.
(1994) - et al.
Distribution of d-amino oxidase (DAO) activity in the medulla and thoracic spinal cord of the rat: implications for a role of d-serine in autonomic function
Brain Res.
(1997) Rat d-amino-acid oxidase cDNA: rat d-amino-acid oxidase as an intermediate form between mouse and other mammalian d-amino-acid oxidases
Biochim. Biophys. Acta
(1998)Rat cerebral serine racemase: amino acid deletion and truncation at carboxy terminus
Neurosci. Lett.
(2003)
Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs
Biochim. Biophys. Acta
NMDA receptor hypofunction model of schizophrenia
J. Psychiatr. Res.
Increased cortical kynurenate content in schizophrenia
Biol. Psychiatry
Gene expression of d-amino acid oxidase in cultured rat astrocytes: regional and cell type specific expression
Neurosci. Lett.
A new colorimetric determination of d-amino acid oxidase and urate oxidase activity
Anal. Biochem.
Comments on risk for schizophrenia
Schizophr. Res.
Characterization and localization of a human serine racemase
Brain Res. Mol. Brain Res.
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels
Biol. Psychiatry
Cited by (67)
d-Amino acids in biological systems
2023, ChiralityA role for endothelial NMDA receptors in the pathophysiology of schizophrenia
2022, Schizophrenia ResearchSynthesis and preliminary evaluation of 4-hydroxy-6-(3-[<sup>11</sup>C]methoxyphenethyl)pyridazin-3(2H)-one, a <sup>11</sup>C-labeled D-amino acid oxidase (DAAO) inhibitor for PET imaging
2020, Bioorganic and Medicinal Chemistry LettersBehavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia
2016, Schizophrenia ResearchCitation Excerpt :In the brain, KYNA is produced by astrocytes and acts as an antagonist at N-Methyl-d-aspartate (NMDA) and α7 nicotinic acetylcholine receptors, providing the biological rationale for using this biomarker for diagnostic purposes and as a target of potential intervention (Bernstein et al., 2009; Schwarcz et al., 2012). Although the exact mechanisms of elevated KYNA levels in schizophrenia remain to be elucidated, both inflammation and genetic variants in the enzymes of the kynurenine pathway (e.g., kynurenine 3-monooxygenase) could be responsible for elevated levels of KYNA (Aoyama et al., 2006; Kapoor et al., 2006; Wonodi et al., 2011; Holtze et al., 2012). Decreased concentrations of a co-agonist of NMDA receptors, d-serine, were detected in the plasma and CSF of patients with schizophrenia.
NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: A meta-analysis of case-control studies
2013, Neuroscience and Biobehavioral Reviews
- 1
Present address: School of Pharmacology and Medicine, University of Western Australia, M510, Perth 6009, Australia.